Concepedia

Clinical development success rates for investigational drugs

Michael Hay, David W. Thomas, John L. Craighead, Celia Economides, Jesse Rosenthal

Nature Biotechnology · 2014 · 2.5K citations · 11 references

DOI

Concepts

References

11

The price of innovation: new estimates of drug development costs

Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski · Journal of Health Economics · 2003 · 4.3K citations · Full text

, , +14

Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery

Rebecca Henderson, Iain Cockburn · The RAND Journal of Economics · 1996 · 1.2K citations

, , +16

The cost of biopharmaceutical R&D: is biotech different?

Joseph A. DiMasi, Henry G. Grabowski · Managerial and Decision Economics · 2007 · 520 citations · Full text

, , +13

Risks in new drug development: Approval success rates for investigational drugs

Joseph A. DiMasi · Clinical Pharmacology & Therapeutics · 2001 · 455 citations

, , +8

Scale, scope, and spillovers: the determinants of research productivity in drug discovery.

Rebecca Henderson, Iain Cockburn · PubMed · 1996 · 420 citations

, , +16